Carl F. Mauch

Contatto Relazioni con gli Investitori presso TCR2 THERAPEUTICS INC.

Health Technology

Finance

Posizioni attive di Carl F. Mauch

Società	Posizione	Inizio	Fine
TCR2 THERAPEUTICS INC.	Contatto Relazioni con gli Investitori	-	-
TCR2 THERAPEUTICS INC.	Public Communications Contact	-	-
ITEOS THERAPEUTICS, INC.	Contatto Relazioni con gli Investitori	-	-
ITEOS THERAPEUTICS, INC.	Public Communications Contact	-	-
Stern Investor Relations, Inc. Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY.	Direttore/Membro del Consiglio	01/01/2016	-

Distribuzione geografica

Stati Uniti

Posizioni

Public Communications Contact	2
Investor Relations Contact	2
Director/Board Member	1

Settori

Health Technology	3
Finance	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ITEOS THERAPEUTICS, INC.	Health Technology

Aziende private	2
Stern Investor Relations, Inc. Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY.	Finance
TCR2 Therapeutics, Inc. TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA.	Health Technology

Aziende private

Finance

Health Technology